202 related articles for article (PubMed ID: 16447037)
1. Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology.
Schwartz KM; Erickson BJ; Lucchinetti C
Neuroradiology; 2006 Mar; 48(3):143-9. PubMed ID: 16447037
[TBL] [Abstract][Full Text] [Related]
2. T2 hypointense rims and ring-enhancing lesions in MS.
Llufriu S; Pujol T; Blanco Y; Hankiewicz K; Squarcia M; Berenguer J; Villoslada P; Graus F; Saiz A
Mult Scler; 2010 Nov; 16(11):1317-25. PubMed ID: 20685762
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
5. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings.
Ashdown BC; Tien RD; Felsberg GJ
AJR Am J Roentgenol; 1994 Jan; 162(1):155-9. PubMed ID: 8273655
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
[TBL] [Abstract][Full Text] [Related]
7. Tongue abscesses: MR imaging findings.
Ozturk M; Mavili E; Erdogan N; Cagli S; Guney E
AJNR Am J Neuroradiol; 2006; 27(6):1300-3. PubMed ID: 16775284
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of pyogenic brain abscesses from necrotic glioblastomas with use of susceptibility-weighted imaging.
Toh CH; Wei KC; Chang CN; Hsu PW; Wong HF; Ng SH; Castillo M; Lin CP
AJNR Am J Neuroradiol; 2012 Sep; 33(8):1534-8. PubMed ID: 22422181
[TBL] [Abstract][Full Text] [Related]
9. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
Abou Zeid N; Pirko I; Erickson B; Weigand SD; Thomsen KM; Scheithauer B; Parisi JE; Giannini C; Linbo L; Lucchinetti CF
Neurology; 2012 May; 78(21):1655-62. PubMed ID: 22573639
[TBL] [Abstract][Full Text] [Related]
11. Intracranial tuberculoma: comparison of MR with pathologic findings.
Kim TK; Chang KH; Kim CJ; Goo JM; Kook MC; Han MH
AJNR Am J Neuroradiol; 1995 Oct; 16(9):1903-8. PubMed ID: 8693993
[TBL] [Abstract][Full Text] [Related]
12. Visceral metastases from melanoma: findings on MR imaging.
Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
[TBL] [Abstract][Full Text] [Related]
13. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.
Koelblinger C; Fruehwald-Pallamar J; Kubin K; Wallner-Blazek M; van den Hauwe L; Macedo L; Puchner SB; Thurnher MM
Eur J Radiol; 2013 Nov; 82(11):1996-2004. PubMed ID: 23993757
[TBL] [Abstract][Full Text] [Related]
14. Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma.
Wasay M; Kheleani BA; Moolani MK; Zaheer J; Pui M; Hasan S; Muzaffar S; Bakshi R; Sarawari AR
J Neuroimaging; 2003 Jul; 13(3):240-7. PubMed ID: 12889171
[TBL] [Abstract][Full Text] [Related]
15. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
[TBL] [Abstract][Full Text] [Related]
16. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
[TBL] [Abstract][Full Text] [Related]
17. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.
Isiklar I; Leeds NE; Fuller GN; Kumar AJ
AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597
[TBL] [Abstract][Full Text] [Related]
18. T2-hypointense rim of breast mass lesions on magnetic resonance images: Radiologic-pathologic correlation.
Nakashima K; Uematsu T; Sugino T; Takahashi K; Nishimura S; Tadokoro Y; Hayashi T
Breast J; 2018 Nov; 24(6):944-950. PubMed ID: 29785726
[TBL] [Abstract][Full Text] [Related]
19. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
Vellinga MM; Oude Engberink RD; Seewann A; Pouwels PJ; Wattjes MP; van der Pol SM; Pering C; Polman CH; de Vries HE; Geurts JJ; Barkhof F
Brain; 2008 Mar; 131(Pt 3):800-7. PubMed ID: 18245785
[TBL] [Abstract][Full Text] [Related]
20. IgG4-related kidney disease: MRI findings with emphasis on the usefulness of diffusion-weighted imaging.
Kim B; Kim JH; Byun JH; Kim HJ; Lee SS; Kim SY; Lee MG
Eur J Radiol; 2014 Jul; 83(7):1057-1062. PubMed ID: 24768583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
